Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches.
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Descriptive Evalaution of Characteristics of Patients Diagnosed with Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents.
Anatomical and functional aspects of mu opioid receptors in epileptic WAG/Rij rats.
Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats.
A case-control study of risk factors for multiple sclerosis in Iran.
The blood-brain barrier in systemic inflammation.
Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China.
Pemetrexed-Induced Nephrogenic Diabetes Insipidus.
Re: Prevalence of Sexual Dysfunctions among Women with Multiple Sclerosis.
Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
Low-Dose Ribavirin Treatments Attenuate Neuroinflammatory Activation of BV-2 Cells by Interfering with Inducible Nitric Oxide Synthase.
The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain.
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.
Rat white matter injury model induced by endothelin-1 injection: technical modification and pathological evaluation.
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
A blood based 12-miRNA signature of Alzheimer disease patients.
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls.
CellCept Drug Details
Cardiac stunning as first manifestation of multiple sclerosis: A case report reminding us not to overlook cardiovascular autonomic dysfunction in multiple sclerosis.

Pages